PHIONX Q1 2026: Revenue Declines, Operating Loss Persists; Convertible Bond Issuance and Management Dispute Weigh on Stock
Consolidated Q1 2026 revenue fell 45% YoY to USD 915,925 (approx. KRW 1.34B), with operating loss of USD 816,373 and net loss of USD 845,769. Although the loss narrowed YoY, fundamental profitability improvement remains insufficient.
In February 2026, a third-party allotment of 1,605,503 new shares at KRW 436 per share raised approximately KRW 714M, increasing total shares to 52,760,502 and diluting existing shareholders.
Two outstanding convertible bonds (Series #29: KRW 3B, conversion price KRW 806; Series #30: KRW 2.4B, conversion price KRW 557). An additional Series #31 CB of KRW 7B (conversion price KRW 436) is planned for issuance (payment due June 18, 2026). Conversion prices near the current stock price (KRW 389) raise concerns of massive dilution upon conversion.
Major shareholder Lux Hoover LLC holds 13.00%, and 5%+ shareholder Bogyeong Housing Construction holds 9.70%. A management dispute lawsuit (Seoul Southern District Court 2026Kahap1239) is ongoing, intensifying shareholder conflict.
No dividends paid in the last 5 years. Accumulated deficit stands at KRW 158.1B (USD 158M) on a consolidated basis; capital is not impaired but financial health is weak, making cash dividends unlikely.
[AI Comprehensive Analysis]PHIONX continues to post losses in both apparel and cannabis segments, with slow profitability improvement. Frequent CB and equity issuances for funding are diluting existing shareholders, while the ongoing management dispute adds significant uncertainty. Short-term stock outlook is negative, and investors should manage risk carefully.